[Congressional Record (Bound Edition), Volume 157 (2011), Part 15] [Extensions of Remarks] [Pages 21099-21100] [From the U.S. Government Publishing Office, www.gpo.gov]HONORING VICTOR GRIFOLS ROURA--SPAIN-U.S. CHAMBER OF COMMERCE 2011 BUSINESS LEADER OF THE YEAR ______ HON. JUDY CHU of california in the house of representatives Thursday, December 15, 2011 Ms. CHU. Mr. Speaker, I rise today to congratulate Mr. Victor Grifols Roura on being honored as the 2011 Business Leader of the Year by the Spain-U.S. Chamber of Commerce. Mr. Grifols Roura is President and CEO of Grifols, a global healthcare company with U.S. headquarters in my congressional district in Los Angeles. Founded in Barcelona, Spain in 1940, Grifols is a leading producer of plasma protein therapies essential for the treatment of a variety of rare, chronic and often life-threatening diseases including: hemophilia, von-Willibrand disease, primary immune deficiencies, and alpha-1 antitrypsin deficiency. All of Grifols medicines are derived from human plasma collected at one of the company's 147 plasma donation centers across the country. For three generations, the Grifols family has been dedicated to improving the lives of patients around the world. One of the company's founders, Dr. Jose Antonio Grifols Roig, developed the plasma donation technique known as plasmapheresis with Dr. Edward Cohn in 1950. Still the method of choice today, plasmapheresis is an automated process that enables individuals to donate plasma while retaining their red blood cells, white blood cells and platelets. This groundbreaking invention gave rise to the modern plasma therapeutics industry. Mr. Speaker, Grifols employs 700 people in its corporate, manufacturing, warehousing, and testing facilities in California's 32nd District. The company has invested $135 million in these facilities since 2003 and is moving forward with plans to add 70 new manufacturing jobs. As part of its commitment to Los Angeles, Grifols supports local organizations that promote education, job training and skills development for area residents. Through an industry partnership with Los Angeles Trade Technical College, Grifols devises curricula and hosts seminars in microbiology, manufacturing, interviewing techniques and resume preparation. Graduating students are given the opportunity to tour the Grifols manufacturing facility and learn about the production of plasma therapies. Grifols also partners with the Wilshire-Metro WorkSource Center, which provides workforce development resources to job seekers and local businesses. Grifols hires interns from the Center who have completed their certificate program in technology. In addition, the company interviews all graduates of the program to provide them with valuable, real-world experience. Grifols presence in the U.S. was greatly enhanced this year by the acquisition of Talecris Biotherapeutics. This transaction, valued at almost $5 billion, is the largest acquisition ever completed by a Spanish company in the U.S. Grifols is now the world's largest collector of human plasma, the third largest manufacturer of plasma protein therapies globally, and the leading plasma manufacturer in Europe. Mr. Speaker, the Spain-U.S. Chamber of Commerce is the leading forum for the promotion of commercial, economic and industrial relations between Spain and the United States. Founded in 1959 and based in New York City, the Chamber is a non-profit organization dedicated to fostering economic outreach between the two countries. The Chamber honored Mr. Grifols at its annual gala dinner in Manhattan on December 6th. The U.S Ambassador to Spain, the Spanish Ambassador to the U.S., and the Spanish Minister of Culture joined over 250 guests in recognizing Mr. Grifols Roura's commitment to fostering expanded economic and social ties between the U.S. and Spain. [[Page 21100]] Mr. Speaker, I ask my colleagues to join me in congratulating Victor Grifols Roura for his outstanding leadership of Grifols and for his well deserved honor as 2011 Business Leader of the Year by the Spain- U.S. Chamber of Commerce. ____________________